Early-Stage Chronic Kidney Disease and Related Health Care Spending
Overview
Affiliations
Importance: The global burden of chronic kidney disease (CKD) is substantial and potentially leads to higher health care resource use.
Objective: To examine the association between early-stage CKD and health care spending and its changes over time in the general population.
Design, Setting, And Participants: Cohort study using nationwide health checkup and medical claims data in Japan. Participants included individuals aged 30 to 70 years with estimated glomerular filtration rates (eGFR) of 30 mL/min/1.73 m2 or greater at the baseline screening in 2014. Data analyses were conducted from April 2021 to October 2023.
Exposure: The CKD stages at baseline, defined by the eGFR and proteinuria, were as follows: eGFR of 60 mL/min/1.73 m2 or greater without proteinuria, eGFR of 60 mL/min/1.73 m2 or greater with proteinuria, eGFR of 30 to 59 mL/min/1.73 m2 without proteinuria, and eGFR of 30 to 59 mL/min/1.73 m2 with proteinuria.
Main Outcome And Measures: The primary outcome was excess health care spending, defined as the absolute difference in health care spending according to the baseline CKD stages (reference group: eGFR ≥60 mL/min/1.73 m2 without proteinuria) in the baseline year (2014) and in the following 5 years (2015 to 2019).
Results: Of the 79 988 participants who underwent a health checkup (mean [SD] age, 47.0 [9.4] years; 22 027 [27.5%] female), 2899 (3.6%) had an eGFR of 60 mL/min/1.73 m2 or greater with proteinuria, 1116 (1.4%) had an eGFR of 30 to 59 mL/min/1.73 m2 without proteinuria, and 253 (0.3%) had an eGFR of 30 to 59 mL/min/1.73 m2 with proteinuria. At baseline, the presence of proteinuria and an eGFR less than 60 mL/min/1.73 m2 were associated with greater excess health care spending (adjusted difference, $178; 99% CI, $6-$350 for proteinuria; $608; 99% CI, $233-$983 for an eGFR of 30-59 mL/min/1.73 m2; and $1254; 99% CI, $134-$2373 for their combination). The study consistently found excess health care spending over the following 5 examined years.
Conclusions And Relevance: In this cohort study of nationwide health checkup and medical claims data in Japan, early-stage CKD was associated with excess health care spending over the 5 examined years, and the association was more pronounced with a more advanced disease stage.
Wang Y, Jiesisibieke Z, Yang Y, Wang B, Hsiung M, Tung T JMIR Public Health Surveill. 2024; 10:e60136.
PMID: 39727265 PMC: 11693784. DOI: 10.2196/60136.
Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney Care.
Correa-Rotter R, Chadban S, Christen L, Damron K, Hamusankwa L, Jarvis S Adv Ther. 2024; 42(2):559-567.
PMID: 39621229 PMC: 11787170. DOI: 10.1007/s12325-024-03048-9.
Otani M, Nonomiya Y, Ihara Y, Kawai R, Taniuchi S, Yoshida H Cureus. 2024; 16(9):e70351.
PMID: 39469391 PMC: 11513208. DOI: 10.7759/cureus.70351.
Iwagami M, Odani K, Saito T Kidney360. 2024; 5(12):1862-1870.
PMID: 39451006 PMC: 11687991. DOI: 10.34067/KID.0000000608.
Huang F, Xie X, Wang M, Tong X, Wu R J Int Med Res. 2024; 52(9):3000605241281874.
PMID: 39324177 PMC: 11437542. DOI: 10.1177/03000605241281874.